Φορτώνει......
MHC-E-restricted CD8+ T cells target Hepatitis B virus-infected human hepatocytes
Currently 247 million people are living with chronic HBV infection (CHB), and the development of novel curative treatments is urgently needed. Immunotherapy is an attractive approach to treat CHB, yet therapeutic approaches to augment the endogenous HBV-specific T cell response in CHB patients have...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Immunol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8109620/ https://ncbi.nlm.nih.gov/pubmed/32161099 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1900795 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|